Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
The drug delivered higher reductions in LDL cholesterol than can currently be achieved with any other drug or intervention.
Canada-listed Sandstorm Gold, which already owns 7% of the AIM-listed company, is offering its own paper as well as 28.75p per share in cash.
The impact of regulatory intervention may be over-egged, says Jefferies.
Higher volumes from key customers and strong demand for pericardium tissue were behind the surge.
The company, which developed and out-licensed AZD9412, believes the interferon beta candidate has potential.
The country is host to the gold explorer’s Tulu Kapi project, which is being developed for production.
The major unknown, the City heavyweight said, was Govia Thameslink Railways, where there is still no update from the Department for Transport on changes to potential franchise terms
He has over 35 years’ experience in the life sciences arena
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.